Skip to main content

Bayforest Capital Ltd

Position in OGN — Organon & Co.

CIK 2048423 LONDON, X0

Position in OGN

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$11,766
-$136,480 QoQ
Shares Held
869
-96.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#339
of 625 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Bayforest Capital Ltd holds $445,312 across 4 Drug Manufacturers - General names. OGN ranks #4 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 OGN
Organon & Co.
This page
869 $11,766

All Filings in OGN

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,766 869
2026-03-31 $148,246 24,749
2025-12-31 $322,843 45,027
2025-09-30 $652,857 61,129
2025-06-30 $10,251 1,059